These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 670485)

  • 1. Effects of dopamine synthesis inhibition on WAIS comprehension.
    Donnelly EF; Nasrallah HA; Wyatt RJ; Gillin JC; Bigelow LB
    J Consult Clin Psychol; 1978 Jun; 46(3):385-8. PubMed ID: 670485
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine.
    Nasrallah HA; Donnelly EF; Bigelow LB; Rivera-Calimlim L; Rogol A; Potkin S; Rauscher FP; Wyatt RJ
    Arch Gen Psychiatry; 1977 Jun; 34(6):649-55. PubMed ID: 17374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification by methyltyrosine methylester (H 44-68) of the amphetamine-induced toxicity and brain catecholamine changes in developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):119-28. PubMed ID: 4741031
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of haloperidol on thought disorder and IQ in schizophrenia.
    Gold JM; Hurt SW
    J Pers Assess; 1990; 54(1-2):390-400. PubMed ID: 2179521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WAIS-IV profile of cognition in schizophrenia.
    Michel NM; Goldberg JO; Heinrichs RW; Miles AA; Ammari N; McDermid Vaz S
    Assessment; 2013 Aug; 20(4):462-73. PubMed ID: 23443820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of clinical status of schizophrenic patients by the WAIS comprehension subtest.
    Bigelow LB; Donnelly EP; Torrey EF; Lee CA
    J Clin Psychiatry; 1979 Jun; 40(6):258-61. PubMed ID: 36371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychological aspects of schizophrenic mental deterioration].
    Roccatagliata G; Arcuri T; Ivaldi M; Fontani L; Maffini M; Cocito L
    Riv Neurol; 1979; 49(6):440-50. PubMed ID: 549213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine hypothermia and brain nicotine and catecholamine levels in the mouse.
    Mansner R; Alhava E; Klinge E
    Med Biol; 1974 Dec; 52(6):390-8. PubMed ID: 4444360
    [No Abstract]   [Full Text] [Related]  

  • 9. MMPI-WAIS relationships in organic and schizophrenic patients.
    Watson CG; Davis WE; McDermott MT
    J Clin Psychol; 1976 Jul; 32(3):539-40. PubMed ID: 956406
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of hospitalized schizophrenics on picture vocabulary (QT) and verbal vocabulary (WAIS) measures.
    Maloney MP; De Young R; Majovsky L
    Psychol Rep; 1975 Aug; 37(1):217-8. PubMed ID: 1153580
    [No Abstract]   [Full Text] [Related]  

  • 11. Reviving and Refining Psychodynamic Interpretation of the Wechsler Intelligence Tests: The Verbal Comprehension Subtests.
    Bram AD
    J Pers Assess; 2017; 99(3):324-333. PubMed ID: 27808557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ontogenic study on the effect of catecholamine receptor-stimulating agents on the turnover of noradrenaline and dopamine in the brain.
    Kellogg C; Wennerström G
    Brain Res; 1974 Oct; 79(3):451-64. PubMed ID: 4371328
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving WAIS-R estimates with the Shipley-Hartford and Wonderlic Personnel Tests: need to control for reading ability.
    Frisch MB; Jessop NS
    Psychol Rep; 1989 Dec; 65(3 Pt 1):923-8. PubMed ID: 2608851
    [No Abstract]   [Full Text] [Related]  

  • 14. Construct validity of neuropsychological tests in schizophrenia.
    Allen DN; Aldarondo F; Goldstein G; Huegel SG; Gilbertson M; van Kammen DP
    Assessment; 1998 Dec; 5(4):365-74. PubMed ID: 9835660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 16. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of alpha-methyltyrosine and disulfiram on inhibitory function of the caudate nucleus and the catecholamine concentration in the cat brain.
    Arushanyan EB; Stolyarov GV; Tolpyshev BA
    Bull Exp Biol Med; 1974 Aug; 77(2):139-42. PubMed ID: 4433917
    [No Abstract]   [Full Text] [Related]  

  • 18. Provocation of schizophrenic symptoms by intravenous administration of methylphenidate.
    Janowsky DS; el-Yousel MK; Davis JM; Sekerke HJ
    Arch Gen Psychiatry; 1973 Feb; 28(2):185-91. PubMed ID: 4630714
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of -methyl-meta-tyrosine on spontaneous and caudate-induced electroencephalogram activity and regional catecholamines in the cat brain.
    Shellenberger MK
    J Pharmacol Exp Ther; 1971 Jun; 177(3):481-90. PubMed ID: 5568803
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ; Alhava E; Mansner R
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.